Key result
Impaired fasting glucose in patients with acute myocardial infarction was associated with a higher rate of in-hospital cardiogenic shock compared to normal fasting glucose (12% vs 6%, P=0.011).
Why the study?
Does impaired fasting glucose increase the risk of adverse in-hospital outcomes such as cardiogenic shock and mortality in patients with acute myocardial infarction?
Population
999 patients with acute myocardial infarction from the RICO survey
Comparison
Impaired Fasting Glucose vs Normal Fasting Glucose
Design
Cohort
Follow-up
in-hospital
Authors
Loading...
Impaired fasting glucose may aid early risk stratification in AMI; leaves open whether glucose-targeted interventions reduce shock.
Observational (n=999)
Does impaired fasting glucose increase the risk of adverse in-hospital outcomes such as cardiogenic shock and mortality in patients with acute myocardial infarction?
Absolute Event Rate: 12% vs 6%
p-value: p=0.011
Impaired fasting glucose is a strong independent predictor of cardiogenic shock and in-hospital mortality in patients presenting with acute myocardial infarction.
Marianne Zeller (2004) conducted an observational in acute myocardial infarction (n=999). Impaired Fasting Glucose (IFG) vs. Normal Fasting Glucose (NFG) was evaluated on Cardiogenic shock (p=0.011). Impaired fasting glucose in patients with acute myocardial infarction was associated with a higher rate of in-hospital cardiogenic shock compared to normal fasting glucose (12% vs 6%, P=0.011).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: